Form 4: Stryker Director Ronda E. Stryker Executes Stock Option and Sells Shares
SEC Form 4 Filing
Ronda E. Stryker, a director at Stryker Corp, exercised stock options and sold a significant number of shares in multiple transactions.
Summary
- Ronda E. Stryker, a director at Stryker Corp, exercised stock options to acquire 3,795 shares of common stock at $93.06 per share on January 30, 2025.
- She then sold a total of 193,402 shares of common stock on January 31, 2025, at prices ranging from $390.90 to $395.60 per share.
- These sales were executed through multiple transactions at weighted average prices.
- The shares were sold from a revocable trust, and some shares were previously transferred from the L. Lee Stryker Trust on November 15, 2024.
- Following these transactions, Ms. Stryker still beneficially owns a substantial number of shares, including those held indirectly through various trusts.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It does not indicate any positive or negative sentiment about the company's performance or future prospects.
Industry Context
This is a routine filing related to insider trading activity, which is common for directors and officers of publicly traded companies. The transactions are not unusual and are part of the normal course of business for individuals holding stock options and large share positions.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, and the transactions reported are typical for corporate insiders.
- The sale of shares by a director is not unusual and is often part of personal financial planning.
- The use of trusts for holding shares is a common practice for estate planning and asset management.
Stakeholder Impact
- The transactions may have a minor impact on the stock price due to the volume of shares sold, but this is likely to be short-term.
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 02/11/2015 | Date of grant for the stock options exercised on January 30, 2025. |
| 11/15/2024 | Date of transfer of 756,859 shares from the L. Lee Stryker Trust to the Revocable Trust. |
| 01/30/2025 | Date Ronda E. Stryker exercised stock options. |
| 01/31/2025 | Date Ronda E. Stryker sold 193,402 shares of common stock. |
| 02/03/2025 | Date of filing of the Form 4. |
Keywords
Stryker, stock options, insider trading, share sales, Form 4, director, beneficial ownership, revocable trust
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.